D. Western Therapeutics Institute, Inc. (FRA:6DW)

FRA:6DW Balance Sheet

Financials in millions JPY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,654	1,126	1,867	2,334	1,933	2,308
Cash & Short-Term Investments	1,654	1,126	1,867	2,334	1,933	2,308
Cash Growth	42.52%	-39.69%	-20.01%	20.75%	-16.25%	49.87%
Accounts Receivable	144.15	125	117	170	101	91
Receivables	144.15	125	117	170	101	91
Inventory	102.39	101	87	79	88	58
Other Current Assets	117.68	123	66	76	40	46
Total Current Assets	2,018	1,475	2,137	2,659	2,162	2,503
Property, Plant & Equipment	9.73	11	10	10	4	5
Long-Term Investments	-	138	138	162	129	20
Other Intangible Assets	12.87	44	86	124	166	208
Other Long-Term Assets	137.89	1	2	1	1	1
Total Assets	2,179	1,669	2,373	2,956	2,462	2,737
Accounts Payable	161.76	-	-	-	-	-
Current Portion of Long-Term Debt	46.55	19	9	120	129	120
Current Income Taxes Payable	1.2	99	173	75	51	56
Other Current Liabilities	10.97	14	12	16	13	33
Total Current Liabilities	220.47	132	194	211	193	209
Long-Term Debt	469.64	778	875	847	210	340
Other Long-Term Liabilities	24	26	25	27	25	25
Total Liabilities	714.12	936	1,094	1,085	428	574
Common Stock	642	1,203	831	714	573	556
Additional Paid-In Capital	1,226	3,261	2,889	2,772	2,631	2,655
Retained Earnings	-404.19	-3,732	-2,442	-1,629	-1,200	-1,051
Comprehensive Income & Other	1.21	1	1	-1	2	3
Total Common Equity	1,465	733	1,279	1,856	2,006	2,163
Minority Interest	-	-	-	15	28	-
Shareholders' Equity	1,465	733	1,279	1,871	2,034	2,163
Total Liabilities & Equity	2,179	1,669	2,373	2,956	2,462	2,737
Total Debt	516.19	797	884	967	339	460
Net Cash (Debt)	1,138	329	983	1,367	1,594	1,848
Net Cash Growth	1028.92%	-66.53%	-28.09%	-14.24%	-13.74%	74.34%
Net Cash Per Share	25.70	9.37	30.93	46.12	54.34	68.01
Filing Date Shares Outstanding	53.14	45.28	32.13	31.32	29.36	29.31
Total Common Shares Outstanding	53.14	41.63	32.13	30.87	29.36	29.25
Working Capital	1,798	1,343	1,943	2,448	1,969	2,294
Book Value Per Share	27.56	17.61	39.81	60.12	68.33	73.95
Tangible Book Value	1,452	689	1,193	1,732	1,840	1,955
Tangible Book Value Per Share	27.32	16.55	37.13	56.10	62.67	66.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.